Pediatric Rehabilitation: 1. Common Medical Conditions in Children With Disabilities

PM and R

Volumn 2, Issue 3, 2010, Pages

  Kim, Chong Tae ^a   Moberg Wolff, Elizabeth ^b   Trovato, Melissa ^c   Kim, Heakyung ^a   Murphy, Nancy ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTICOAGULANT AGENT; BACLOFEN; BISPHOSPHONIC ACID DERIVATIVE; BOTULINUM TOXIN; BROMOCRIPTINE; CARBAMAZEPINE; CHLORPROMAZINE; ETIDRONIC ACID; GABAPENTIN; GLYCOPYRRONIUM BROMIDE; METHYLPHENIDATE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; PHENOBARBITAL; PHENYTOIN; PINDOLOL; PROPRANOLOL; SCOPOLAMINE; TRAZODONE; VALPROIC ACID; VITAMIN D; ZOLPIDEM;

ACCOMMODATION PARALYSIS; AGITATION; AROUSAL; ARTICLE; ASPIRATION PNEUMONIA; BONE DISEASE; BRACE; BRADYCARDIA; BRONCHUS SECRETION; CENTRAL DYSAUTONOMIA; CEREBRAL PALSY; COMPRESSION GARMENT; CONSTIPATION; DEEP VEIN THROMBOSIS; DIZZINESS; DROWSINESS; DRUG WITHDRAWAL; DRY SKIN; DYSAUTONOMIA; DYSPHAGIA; FLUSHING; GASTROESOPHAGEAL REFLUX; GRANULOMA; HANDICAPPED CHILD; HETEROTROPIC OSSIFICATION; HUMAN; HYPERSALIVATION; HYPOPITUITARISM; IRRITABILITY; LUNG EMBOLISM; MEDICAL EDUCATION; MYDRIASIS; NONHUMAN; NUTRITION; ORTHOSIS; ORTHOSTATIC HYPOTENSION; OSTEOGENESIS IMPERFECTA; OSTEOPOROSIS; PEDIATRIC REHABILITATION; PHOTOPHOBIA; PHYSICAL MEDICINE; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; RASH; RECURRENT DISEASE; RESTLESSNESS; RICKETS; RISK FACTOR; SCOLIOSIS; SEIZURE; SIDE EFFECT; SLEEP DISORDER; TRACHEA STENOSIS; TRAUMATIC BRAIN INJURY; TRAUMATIC EPILEPSY; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT; URINARY URGENCY; URINE RETENTION; VENA CAVA FILTER; VITAMIN D DEFICIENCY; VOCAL CORD PARALYSIS; XEROSTOMIA;

BRAIN INJURIES; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; DISABLED CHILDREN; EPILEPSY, POST-TRAUMATIC; FEMALE; HUMANS; MALE; OSTEOPOROSIS; PHYSICAL THERAPY MODALITIES; SCOLIOSIS;

EID: 77950251710     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2009.12.004     Document Type: Article

References (120)

1. **Indicates key references.
2. Formisano R., Barba C., Buzzi M.G., et al. The impact of prophylactic treatment on post-traumatic epilepsy after severe traumatic brain injury. Brain Inj 21 (2007) 499-504
3. *
4. *
5. Appleton R.E., and Demellweek C. Post-traumatic epilepsy in children requiring inpatient rehabilitation following head injury. J Neurol Neurosurg Psychiatry 72 (2002) 669-672
6. Medical Research Council Antiepileptic Drug Withdrawal Study Group. Randomised study of antiepileptic drug withdrawal in patients in remission. Lancet 337 (1991) 1175-1180
7. Shinnar S., Vining E.P., Mellits E.D., et al. Discontinuing antiepileptic medication in children with epilepsy after two years without seizure. A prospective study. N Engl J Med 313 (1985) 976-980
8. Chadwick D., Taylor J., and Johnson T. Outcomes after seizure recurrence in people with well-controlled epilepsy and the factors that influence it. The MRC Antiepileptic Drug Withdrawal Group. Epilepsia 37 (1996) 1043-1050
9. *
10. Peters A.C., Brouwer O.F., Geerts A.T., Arts W.F., Stroink H., and van Donselaar C.A. Randomized prospective study of early discontinuation of antiepileptic drugs in children with epilepsy. Neurology 50 (1998) 724-730
11. Andersson T., Braathen G., Persson A., and Theorell K. A comparison between one and three years of treatment in uncomplicated childhood epilepsy: A prospective study. II. The EEG as predictor of outcome after withdrawal of treatment. Epilepsia 38 (1997) 225-232
12. Delgado-Escueta A.V., and Enrile-Bacsal F. Juvenile myoclonic epilepsy of Janz. Neurology 34 (1984) 285-294
13. Fernandez-Ortega J.F., Prieto-Palomino M.A., Munoz-Lopez A., Lebron-Gallardo M., Cabrera-Ortiz H., and Quesada-Garcia G. Prognostic influence and computed tomography findings in dysautonomic crises after traumatic brain injury. J Trauma 61 (2006) 1129-1133
14. *
15. *
16. Meythaler J.M., and Stinson III A.M. Fever of central origin in traumatic brain injury controlled with propranolol. Arch Phys Med Rehabil 75 (1994) 816-818
17. *
18. Blackman J.A., Patrick P.D., Buck M.L., and Rust Jr. R.S. Paroxysmal autonomic instability with dystonia after brain injury. Arch Neurol 61 (2004) 321-328
19. Cuny E., Richer E., and Castel J.P. Dysautonomia syndrome in the acute recovery phase after traumatic brain injury: Relief with intrathecal Baclofen therapy. Brain Inj 15 (2001) 917-925
20. Baguley I.J., Heriseanu R.E., Gurka J.A., Nordenbo A., and Cameron I.D. Gabapentin in the management of dysautonomia following severe traumatic brain injury: A case series. J Neurol Neurosurg Psychiatry 78 (2007) 539-541
21. *
22. Cyr C., Michon B., Pettersen G., David M., and Brossard J. Venous thromboembolism after severe injury in children. Acta Haematol 115 (2006) 198-200
23. Azu M.C., McCormack J.E., Scriven R.J., Brebbia J.S., Shapiro M.J., and Lee T.K. Venous thromboembolic events in pediatric trauma patients: Is prophylaxis necessary?. J Trauma-Inj Infect Crit Care 59 (2005) 1345-1349
24. Simosa H.F., Petersen D.J., Agarwal S.K., Burke P.A., and Hirsch E.F. Increased risk of deep venous thrombosis with endovascular cooling in patients with traumatic head injury. Am Surgeon 73 (2007) 461-464
25. Radecki R.T., and Gaebler-Spira D. Deep vein thrombosis in the disabled pediatric population. Arch Phys Med Rehabil 75 (1994) 248-250
26. *
27. Truitt A.K., Sorrells D.L., Halvorson E., Starring J., Kurkchubasche A.G., Tracy Jr. T.F., and Luks F.I. Pulmonary embolism: Which pediatric trauma patients are at risk?. J Pediatr Surg 40 (2005) 124-127
28. *
29. Danish S.F., Burnett M.G., Ong J.G., Sonnad S.S., Maloney-Wilensky E., and Stein S.C. Prophylaxis for deep vein thrombosis in craniotomy patients: A decision analysis. Neurosurg 56 (2005) 1286-1292
30. *
31. Aschwanden M., Labs K.H., Engel H., et al. Acute deep vein thrombosis: early mobilization does not increase the frequency of pulmonary embolism. Thromb Haemost 85 (2001) 42-46
32. *
33. *
34. Stelfox H.T., Crimi C., Berra L., et al. Determinants of tracheostomy decannulation: An international survey. Crit Care 12 (2008) R26
35. Rapp R.P., Young B., Ott L., et al. The favorable effect of early parenteral feeding on survival in head-injured patients. J Neurosurg 58 (1983) 906-912
36. Pepe J.L., and Barba C.A. The metabolic response to acute traumatic brain injury and implications for nutritional support. J Head Trauma Rehabil 14 (1999) 462-474
37. *
38. Young B., Ott L., Twyman D., et al. The effect of nutritional support on outcome from severe head injury. J Neurosurg 67 (1987) 668-676
39. *
40. Kudsk K.A., and Teasley-Strausburg K.M. Enteral Nutrition. In: Corson J.D., and Williamson R.C.N. (Eds). Surgery (2001), Mosby, New York 12-18 1, 8
41. Michaud L., Guimber D., Blain-Stregloff A.S., Ganga-Zandzou S., Gottrand F., and Turck D. Longevity of balloon-stabilized skin-level gastrostomy device. J Pediatr Gastroentrol Nutr 38 (2004) 426-429
42. Pedoto M.J., O'Dell M.W., Thrun M., and Hollifield D. Superior mesenteric artery syndrome in traumatic brain injury: Two cases. Arch Phys Med Rehabil 76 (1995) 871-875
43. *
44. *
45. Haselkorn J.K., Britell C.W., and Cardenas D.D. Diagnostic imaging of heterotopic ossification with coexistent deep-venous thrombosis in flaccid paraplegia. Arch Phys Med Rehabil 72 (1991) 227-229
46. *
47. Hendricks H.T., Geurts A.C., van Ginneken B.C., Heeren A.J., and Vos P.E. Brain injury severity and autonomic dysregulation accurately predict heterotopic ossification in patients with traumatic brain injury. Clin Rehabil 21 (2007) 545-553
48. Subbarao J.V., and Garrison S.J. Heterotopic ossification: Diagnosis and management, current concepts and controversies. J Spinal Cord Med 22 (1999) 273-283
49. Rivkees S.A. Differentiating appropriate antidiuretic hormone secretion, inappropriate antidiuretic hormone secretion and cerebral salt wasting: The common, uncommon, and misnamed. Curr Opinion Pediatr 20 (2008) 448-452
50. Acerini C.L., and Tasker R.C. Endocrine sequelae of traumatic brain injury in childhood. Hormone Res 68 Suppl 5 (2007) 14-17
51. *
52. *
53. *
54. Hornyak J.E., Nelson V.S., and Hurvitz E.A. The use of methylphenidate in paediatric traumatic brain injury. Pediatr Rehabil 1 (1997) 15-17
55. Jha A., Weintraub A., Allshouse A., et al. A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. J Head Trauma Rehabil 23 (2008) 52-63
56. *
57. Flanagan S.R., Greenwald B., and Wieber S. Pharmacological treatment of insomnia for individuals with brain injury. J Head Trauma Rehabil 22 (2007) 67-70
58. Shames J.L., and Ring H. Transient reversal of anoxic brain injury-related minimally conscious state after zolpidem administration: A case report. Arch Phys Med Rehabil 89 (2008) 386-388
59. Singh R., McDonald C., Dawson K., et al. Zolpidem in a minimally conscious state. Brain Inj 22 (2008) 103-106
60. Sachdev P., and Kruk J. Restlessness: The anatomy of a neuropsychiatric symptom. Aust N Z Psychiatry 30 (1996) 38-50
61. *
62. Corrigan J.D. Development of a scale for assessment of agitation following traumatic brain injury. J Clin Exp Neuropsychol 11 (1989) 261-277
63. Yudofsky S.C., Silver J.M., Jackson W., Endicott J., and Williams D. The Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J Psychiatry 143 (1987) 35-39
64. Alderman N., Knight C., and Morgan C. Use of a modified version of the Overt Aggression Scale in the measurement and assessment of aggressive behaviors following brain injury. Brain Inj 11 (1997) 503-523
65. Fleminger S., Greenwood R.J., Oliver D.L., et al. Pharmacological management for agitation and aggression in people with acquired brain injury. Cochrane Database of Systematic Reviews Issue 1 (2003) Art. No.: CD003299. DOI: 10.1002/14651858.CD003299
66. Cook S.P., Lawless S., Mandell G.A., and Reilly J.S. The use of the salivagram in the evaluation of severe and chronic aspiration. Int J Pediatr Otorhinolaryngol 41 (1997) 353-361
67. *
68. Blasco P.A., and Allaire J.H. Drooling in the developmentally disabled: Management practices and recommendations. Consortium on Drooling. Dev Med Child Neurol 34 (1992) 849-862
69. Crysdale W.S. Management options for the drooling patient. Ear Nose Throat J 68 (1989) 820-830
70. Tahmassebi J.F., and Curzon M.E. Prevalence of drooling in children with cerebral palsy attending special schools. Develop Med Child Neurol 45 (2003) 613-617
71. Jongerius P.H., van Limbeek J., and Rotteveel J.J. Assessment of salivary flow rate: Biologic variation and measure error. Laryngoscope 114 (2004) 1801-1804
72. Mirrett P.L., Riski J.E., Glascott J., and Johnson V. Videofluoroscopic assessment of dysphagia in children with severe spastic cerebral palsy. Dysphagia 9 (1994) 174-179
73. Collier B.D. Detection of aspiration: Scintigraphic techniques. Am J Med 103 (1997) 135S-137S
74. Akbunar A.T., Kiristioglu I., Alper E., and Demiray H. Diagnosis of orotracheal aspiration using radionuclide salivagram. Ann Nucl Med 17 (2003) 415-416
75. Inga C.T., Reddy A.K., Richardson J.A., and Sanders B. Application of chronic drooling in cerebral palsy patients. Am Acad Pediatr Dent 23 (2001) 241-242
76. *
77. Teymoortash A., Sommer F., Mandic R., et al. Intraglandular application of botulinum toxin leads to structural and functional changes in rat acinar cells. Br J Pharmacol 152 (2007) 161-167
78. Suskind D.L., and Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope 112 (2002) 73-81
79. Savarese R., Diamond M., Elovic E., and Millis S.R. Intraparotid injection of botulinum toxin A as a treatment to control sialorrhea in children with cerebral palsy. Am J Phys Med Rehabil 83 (2004) 304-311
80. Jongerius P.H., Rotteveel J.J., van Limbeek J., Gabreels F.J., van Hulst K., and van den Hoogen F.J. Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology 63 (2004) 1371-1375
81. Ondo W.G., Hunter C., and Moore W. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease. Neurology 62 (2004) 37-40
82. Tan E.K. Botulinum toxin treatment of sialorrhea: Comparing different therapeutic preparations. Eur J Neurol 13 Suppl 1 (2006) 60-64
83. Costa J., Rocha M.L., Ferreira J., Evangelista T., Coelho M., and de Carvalho M. Botulinum toxin type-B improves sialorrhea and quality of life in bulbar onset amyotrophic lateral sclerosis. J Neurol 255 (2008) 545-550
84. Kim H., Lee Y., Weiner D., Kaye R., Cahill A.M., and Yudkoff M. Botulinum toxin type A injections to salivary glands: Combination with single event multilevel chemoneurolysis in 2 children with severe spastic quadriplegic cerebral palsy. Arch Phys Med Rehabil 87 (2006) 141-144
85. Raval T.H., and Elliott C.A. Botulinum toxin injection to the salivary glands for the treatment of sialorrhea with chronic aspiration. Ann Otol Rhinol Laryngol 117 (2008) 118-122
86. *
87. Tejas H., and Elliott C.A. Botulinum toxin injection to salivary glands for treatment of sialorrhea with chronic aspiration. Ann Otol Rhinol Laryngol 117 (2008) 118-122
88. Pena A.H., Cahill A.M., Gonzalez L., Baskin K.M., Kim H., and Towbin R.B. Botulinum toxin A injection of salivary glands in children with drooling and chronic aspiration. J Vasc Interv Radiol 20 (2009) 368-373
89. Apkon S. Osteoporosis in children who have disabilities. Phys Med Rehabil Clin N Am 13 (2002) 839-855
90. *
91. Leet A.I., Mesfin A., Pichard C., et al. Fractures in children with cerebral palsy. J Pediatr Orthop 26 (2006) 624-627
92. Presedo A., Dabney K., and Miller F. Fractures in patients with cerebral palsy. J Pediatr Orthop 27 (2007) 147-153
93. Stevenson R.D., Conaway M., Barrington J.W., Cuthill S.L., Worley G., and Henderson R.C. Fracture rate in children with cerebral palsy. Pediatr Rehab 9 (2006) 396-403
94. Henderson R.C., Lin P.P., and Greene W.B. Bone-mineral density in children and adolescents who have spastic cerebral palsy. J Bone Joint Surg 77 (1995) 1671-1681
95. King W., Levin R., Schmidt R., Oestreich A., and Heubi J. Prevalence of reduced bone mass in children and adults with spastic quadriplegia. Dev Med Child Neurol 45 (2003) 12-16
96. *
97. Harcke H.T., Taylor A., Bachrach S., Miller F., and Henderson R.C. Lateral femoral scan: An alternative method for assessing bone mineral density in children with cerebral palsy. Pediatr Padiol 28 (1998) 241-246
98. *
99. Sullivan P.B., Lambert B., Rose M., Ford-Adams M., Johnson A., and Griffiths P. Prevalence and severity of feeding problems in children with neurological impairment: Oxford Feeding Study. Dev Med Child Neurol 42 (2000) 674-680
100. Hillesund E., Skranes J., Trygg K.U., and Bohmer T. Micronutrient status in children with cerebral palsy. Acta Paediatr 96 (2007) 1195-1198
101. Henderson R.C. Vitamin D levels in noninstitutionalized children with cerebral palsy. J Child Neurol 12 (1997) 443-447
102. Matthews D.J., and Wilson P. Cerebral palsy. In: Molnar G.E., and Alexander M.A. (Eds). Pediatric Rehabilitation (1999), Hanley & Belfus, Inc, Philadelphia, PA 193-218
103. Gissel T., Poulsen C.S., and Vestergaard P. Adverse effects of antiepileptic drugs on bone mineral density in children. Expert Opin Drug Saf 6 (2007) 267-278
104. Caulton J.M., Ward K.A., Alsop C.W., Dunn G., Adams J.E., and Mughal M.Z. A randomised controlled trial of standing programme on bone mineral density in non-ambulant children with cerebral palsy. Arch Dis Child 89 (2004) 131-135
105. Chad K.E., Bailey D.A., McKay H.A., Zello G.A., and Snyder R.E. The effect of a weight-bearing physical activity program on bone mineral content and estimated volumetric density in children with spastic cerebral palsy. J Pediatr 135 (1999) 115-117
106. *
107. Dorman J. Pediatric Orthopaedics: Core Knowledge in Orthopedics (2005), Elsevier Mosby, Philadelphia, PA
108. Olafsson Y., Saraste H., and AlDabbagh Z. Brace treatment in neuromuscular spine deformity. J Ped Orthop 19 (1999) 376-379
109. Gupta M.C., Wijesekera S., Sossan A., et al. Reliability of radiographic parameters in neuromuscular scoliosis. Spine 15 (2007) 691-695 32
110. Staheli L. Practice of Pediatric Orthopedics. 2nd ed (2006), Lippincott Williams Wilkins, Philadelphia, PA
111. Leopando M., Moussavi Z., Holbrow J., et al. Effect of a Soft Boston Orthosis on pulmonary mechanics in severe cerebral palsy. Pediatric Pulm 28 (1999) 53-58
112. Letts M., Rathbone D., Yamashita T., Nichol B., and Keeler A. Soft Boston Orthosis in management of neuromuscular scoliosis: A preliminary report. J Pediatr Orthop 12 (1992) 470-474
113. Nash C.L., and Moe J.H. A study of vertebral rotation. J Bone Joint Surg Am 5 (1969) 223-229
114. Cramer K., and Scherl S. Orthopedic Surgery Essentials. Pediatrics (2004), Lippincott Williams & Wilkins, Philadelphia, PA 44-51
115. Toree-Healy A., and Samdani A.F. Newer technologies for the treatment of scoliosis in the growing spine. Neruosurg Clin N Am 18 (2007) 697-705
116. Smith J.T. The use of growth-sparing instrumentation in pediatric spinal deformity. Ortho Clin North Am 38 (2007) 547-552
117. Murphy N., Firth S., Jorgensen T., and Young P. Spinal surgery in children with idiopathic and neuromuscular scoliosis. What's the difference?. J Ped Ortho 23 (2006) 211-220
118. Hedequist D.J. Surgical treatment of congenital scoliosis. Ortho Clin North Am 38 (2007) 497-509
119. Hell A.K., Campbell R.M., and Hefti F. The vertical expandable prosthetic titanium rib implant for the treatment of thoracic insufficiency syndrome associated with congenital and neuromuscular scoliosis in young children. J Ped Ortho B 13 (2005) 287-293
120. Larsson E., Normelli H., and Oberg B. Long-term follow-up of functioning after spinal surgery in patients with neuromuscular scoliosis. Spine 30 (2005) 2145-2152